Ad is loading...
NUVB
Price
$2.63
Change
-$0.24 (-8.36%)
Updated
Nov 15 closing price
100 days until earnings call
QTTB
Price
$32.95
Change
-$2.68 (-7.52%)
Updated
Nov 15 closing price
Ad is loading...

NUVB vs QTTB

Header iconNUVB vs QTTB Comparison
Open Charts NUVB vs QTTBBanner chart's image
Nuvation Bio
Price$2.63
Change-$0.24 (-8.36%)
Volume$3.31M
CapitalizationN/A
Q32 Bio
Price$32.95
Change-$2.68 (-7.52%)
Volume$121.14K
CapitalizationN/A
NUVB vs QTTB Comparison Chart
Loading...
NUVB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
QTTB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
NUVB vs. QTTB commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NUVB is a Sell and QTTB is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (NUVB: $2.63 vs. QTTB: $32.95)
Brand notoriety: NUVB and QTTB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NUVB: 181% vs. QTTB: 120%
Market capitalization -- NUVB: $885.17M vs. QTTB: $401.35M
NUVB [@Biotechnology] is valued at $885.17M. QTTB’s [@Biotechnology] market capitalization is $401.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NUVB’s FA Score shows that 0 FA rating(s) are green whileQTTB’s FA Score has 0 green FA rating(s).

  • NUVB’s FA Score: 0 green, 5 red.
  • QTTB’s FA Score: 0 green, 5 red.
According to our system of comparison, NUVB is a better buy in the long-term than QTTB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NUVB’s TA Score shows that 6 TA indicator(s) are bullish while QTTB’s TA Score has 5 bullish TA indicator(s).

  • NUVB’s TA Score: 6 bullish, 4 bearish.
  • QTTB’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, NUVB is a better buy in the short-term than QTTB.

Price Growth

NUVB (@Biotechnology) experienced а -8.68% price change this week, while QTTB (@Biotechnology) price change was -27.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.92%. For the same industry, the average monthly price growth was -6.94%, and the average quarterly price growth was -0.62%.

Reported Earning Dates

NUVB is expected to report earnings on Feb 26, 2025.

QTTB is expected to report earnings on May 13, 2024.

Industries' Descriptions

@Biotechnology (-8.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NUVB($885M) has a higher market cap than QTTB($401M). QTTB YTD gains are higher at: 5319.408 vs. NUVB (74.172). NUVB has more cash in the bank: 577M vs. QTTB (108M). NUVB has less debt than QTTB: NUVB (14.7M) vs QTTB (19.9M).
NUVBQTTBNUVB / QTTB
Capitalization885M401M221%
EBITDA-534.2MN/A-
Gain YTD74.1725319.4081%
P/E RatioN/AN/A-
Revenue1.44MN/A-
Total Cash577M108M534%
Total Debt14.7M19.9M74%
FUNDAMENTALS RATINGS
QTTB: Fundamental Ratings
QTTB
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NUVBQTTB
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
80%
Momentum
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
85%
MACD
ODDS (%)
Bullish Trend 5 days ago
76%
Bearish Trend 4 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
88%
Advances
ODDS (%)
Bullish Trend 8 days ago
78%
Bullish Trend 13 days ago
84%
Declines
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
81%
Aroon
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
85%
View a ticker or compare two or three
Ad is loading...
NUVB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
QTTB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSAKX16.79-0.05
-0.30%
Goldman Sachs International Eq Inc A
RMBNX46.36-0.18
-0.39%
RMB Mendon Financial Services C
MIRTX37.80-0.46
-1.20%
MFS Massachusetts Investors Tr R2
MNOSX32.29-0.40
-1.22%
Manning & Napier Overseas Series S
EFCIX21.58-0.60
-2.71%
Emerald Insights Institutional

NUVB and

Correlation & Price change

A.I.dvisor indicates that over the last year, NUVB has been loosely correlated with STOK. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if NUVB jumps, then STOK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUVB
1D Price
Change %
NUVB100%
-8.36%
STOK - NUVB
52%
Loosely correlated
-13.58%
STRO - NUVB
50%
Loosely correlated
-16.23%
KOD - NUVB
40%
Loosely correlated
+4.34%
VCYT - NUVB
40%
Loosely correlated
-2.97%
INZY - NUVB
39%
Loosely correlated
-8.89%
More

QTTB and

Correlation & Price change

A.I.dvisor indicates that over the last year, QTTB has been loosely correlated with MESO. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if QTTB jumps, then MESO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QTTB
1D Price
Change %
QTTB100%
-7.52%
MESO - QTTB
57%
Loosely correlated
-11.31%
STOK - QTTB
48%
Loosely correlated
-13.58%
STRO - QTTB
29%
Poorly correlated
-16.23%
NUVB - QTTB
28%
Poorly correlated
-8.36%
IMNN - QTTB
27%
Poorly correlated
-3.66%
More